| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | 1 | — | — | 2 | 3 | — | 3 | 1 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 0.90 |
—
—
—
|
| 2025 | 0.67 |
—
—
—
—
|
| 2024 | 0.50 |
—
—
—
—
|
| 2023 | 0.42 |
—
—
—
—
|
| 2022 | 0.34 |
—
—
—
—
|
| 2021 | 0.27 |
—
—
—
—
|
| 2020 | 0.23 |
—
—
—
—
|
| 2019 | 0.19 |
—
—
—
—
|
| 2018 | 0.16 |
—
—
—
—
|
| 2017 | 0.16 |
—
—
—
—
|
| 2016 | 0.16 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 451.57 | 565.92 | 642.16 | 660.81 |
| Receivables | 242.49 | 249.53 | 290.82 | 236.03 |
| Inventory | — | — | — | — |
| Other | 27.89 | 71.00 | 35.07 | 58.33 |
| 781.65 | 936.32 | 1,028.07 | 1,023.21 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 116.94 | 123.61 | 135.62 | 154.99 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 611.56 | 613.53 | 666.70 | 647.72 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 712.24 | 762.46 | — | — |
—
|
| ’25 | 635.91 | 685.87 | 700.82 | 802.31 |
2,824.92
|
| ’24 | 594.02 | 625.10 | 640.18 | 726.63 |
2,585.92
|
| ’23 | 560.74 | 590.85 | 598.35 | 676.22 |
2,426.15
|
| ’22 | 537.43 | 555.68 | 547.68 | 667.54 |
2,308.32
|
| ’21 | 473.05 | 498.50 | 509.10 | 594.23 |
2,074.88
|
| ’20 | 443.64 | 403.75 | 426.90 | 509.36 |
1,783.64
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 92.24 | 194.26 | — | — |
—
|
| ’25 | 99.09 | 113.64 | 207.61 | 164.16 |
584.49
|
| ’24 | 53.08 | 80.23 | 125.51 | 151.70 |
410.51
|
| ’23 | 50.73 | 69.05 | 104.32 | 136.52 |
360.62
|
| ’22 | (14.66) | 30.81 | 68.88 | 65.66 |
150.69
|
| ’21 | 32.93 | 77.51 | 99.12 | 59.54 |
269.10
|
| ’20 | 38.85 | 79.74 | 88.09 | 91.25 |
297.93
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 81.51 | 184.15 | — | — |
—
|
| ’25 | 89.85 | 103.30 | 199.73 | 157.62 |
550.51
|
| ’24 | 46.66 | 72.60 | 118.45 | 143.64 |
381.34
|
| ’23 | 44.75 | 64.25 | 98.57 | 130.39 |
337.95
|
| ’22 | (23.24) | 20.38 | 60.07 | 56.51 |
113.73
|
| ’21 | 26.54 | 69.22 | 90.05 | 48.65 |
234.46
|
| ’20 | 23.63 | 73.45 | 80.37 | 86.04 |
263.48
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.54 | 0.57 | — | — |
—
|
| ’25 | 0.30 | 0.50 | 0.50 | 0.79 |
2.09
|
| ’24 | 0.24 | 0.40 | 0.39 | 0.75 |
1.77
|
| ’23 | 0.13 | 0.28 | 0.32 | 0.66 |
1.40
|
| ’22 | 0.03 | 0.37 | 0.22 | 0.43 |
1.04
|
| ’21 | 0.24 | 0.32 | 0.32 | 0.41 |
1.31
|
| ’20 | 0.20 | 0.14 | 0.20 | 0.06 |
0.60
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 27.59 | 32.48 | 41.55 | 44.83 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 48.42 | 49.54 | 58.16 | 71.23 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,800 | 5,900 | 5,900 | 6,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.40 | 0.41 | 0.44 | 0.47 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,308.32 | 2,426.15 | 2,585.92 | 2,824.92 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 47.63% | 48.52% | 49.36% | 50.81% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 236.00 | 302.59 | 383.42 | 451.26 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 10.22% | 12.47% | 14.83% | 15.97% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 173.91 | 232.75 | 293.83 | 343.98 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 92.58 | 95.35 | 92.02 | 95.15 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.83 | 14.73 | 15.73 | 17.31 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 1.04 | 1.41 | 1.79 | 2.11 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.90 | 2.19 | 2.50 | 3.58 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.22) | (0.14) | (0.18) | (0.21) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.68 | 2.05 | 2.32 | 3.37 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.59 | 10.70 | 11.72 | 12.51 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 166.87 | 164.72 | 164.43 | 163.16 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31.48 | 33.70 | 29.08 | 32.90 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.39 | 3.25 | 3.31 | 4.01 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.45 | 4.47 | 4.44 | 5.55 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.27 | 3.09 | 3.12 | 3.81 | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 46.05 | 22.20 | 21.14 | 19.53 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 150.69 | 360.62 | 410.51 | 584.49 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (36.96) | (22.67) | (29.17) | (33.98) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 113.73 | 337.95 | 381.34 | 550.51 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 84.47 | 170.09 | 322.79 | 361.37 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 69.00 | — | — | — | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (278.36) | (451.57) | (565.92) | (642.16) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,599.97 | 1,763.22 | 1,927.21 | 2,041.36 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.82% | 8.86% | 10.58% | 11.78% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.55% | 13.16% | 16.12% | 19.28% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 11.07% | 13.82% | 15.92% | 17.34% | — | — | — |
ROE
|
The New York Times Company (NYT) has masterfully reinvented itself from a print-era giant into a digital subscription juggernaut, with revenue surging 66% to $2.59 billion from 2016-2024, driven by over 70% subscription reliance and hits like Wordle acquisitions, podcasts, and gaming. Pandemic-fueled subscriber booms and disciplined cost controls lifted profitability dramatically—EBT up 1,257% to $383 million, EPS from $0.18 to $1.79, and free cash flow per share quadrupling to $2.32—bolstered by a fortress balance sheet featuring negative net debt and ROE at 15.9%. Forecasts promise steady acceleration to $3.25 billion revenue and nearly $3 EPS by 2027, underscoring its moat in premium journalism.
Yet, as the stock hovers near early 2026 highs with trailing P/E at 29x and conservative analyst targets implying minimal upside, caution flags abound: insider selling without buys, eroding print ads, AI lawsuits siphoning cash, and macro threats to discretionary spending. Valuation multiples like 21x EV/FCF price in perfection, leaving room for contraction if subscriber growth dips below 10% amid competition from Substack or TikTok.
This blend of resilient compounding and lurking risks positions NYT as a steady compounder worth watching—ideal for income seekers holding cash for dips, but demanding vigilance on whether digital tailwinds can outpace cyclical headwinds.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.